Quadruple co-infection with Mycobacterium tuberculosis complex and M. kansasii in a chronically immunosuppressed cat Authors: Sungyoung Choi, Soo-Nyun Choi, Tak Gyeom Lee, Sungweon Ryoo, Ji-Hoon Kwak, Kun-Woo Kim, Tae In Park, Woo-Jin Song, Eun-Joo Lee, Kyu-Shik Jeong Published: 2026 ABSTRACT An 8-year-old spayed female American Shorthair cat was evaluated for refractory perioral nodules and respiratory distress persisting for 9 months. The patient had a history of feline atopy and chronic gingivostomatitis managed with long-term immunosuppressive therapy, including cyclosporine A and prednisolone. Pre-surgical computed tomography (CT) revealed a 2.1 cm nasolabial mass without osteolysis, later diagnosed as a mycobacterial infection. This unusual infection was tentatively attributed to pharmacological suppression of cell-mediated immunity, potentially impairing both granuloma formation and inflammatory bone resorption. Fine-needle aspiration (FNA) and Ziehl–Neelsen (ZN) staining demonstrated a high burden of acid-fast bacilli (AFB). However, conventional cultures, including inoculation on 3% Ogawa medium, failed due to rapid overgrowth of Klebsiella pneumoniae (K. pneumoniae). Post-mortem multi-target real-time PCR and whole genome sequencing (WGS), together with internal transcribed spacer (ITS) sequencing and phenotypic antimicrobial testing, identified a fatal co-infection comprising Mycobacterium tuberculosis complex (MTBC), Mycobacterium kansasii, K. pneumoniae, and multidrug-resistant Pseudomonas aeruginosa. This report describes a rare feline case of a fatal polymicrobial infection involving both MTBC and non-tuberculous mycobacteria (NTM) in conjunction with opportunistic gram-negative pathogens. The findings suggest that chronic iatrogenic immunosuppression may alter or obscure classical diagnostic features of mycobacteriosis and facilitate complex co-infections. This case highlights the importance of high-sensitivity molecular diagnostics and suggests that immunocompromised companion animals may, in rare instances, serve as cautious indicators of possible household mycobacterial exposure within a One Health framework.Graphical abstract Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s11259-026-11427-6. Background Feline mycobacteriosis is a relevant One Health concern because domestic cats live in close proximity to humans and, in rare instances, may be implicated in zoonotic or reverse-zoonotic transmission of mycobacterial agents. Infections involving both Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM) pose substantial diagnostic challenges, particularly in urban environments where human, animal, and environmental interfaces are closely interconnected (Didkowska et al. 2024; Marianelli et al. 2024; Sawyer et al. 2023). Iatrogenic immunosuppression further complicates disease recognition. Calcineurin inhibitors such as cyclosporine A suppress T-cell activation and cytokine signaling, while corticosteroids impair macrophage function and granuloma formation (Motiee et al. 2022; Webster et al. 2022). As a result, infected hosts may show atypical inflammatory responses, and classical features such as well-defined granulomas may be reduced or absent (ABCD Guidelines 2024; Gunn-Moore 2014). This altered immune state may not only obscure typical clinicoradiological findings but could also predispose patients to opportunistic co-infections. In human medicine, tuberculosis is frequently associated with secondary infections involving organisms such as Klebsiella pneumoniae and Pseudomonas aeruginosa, with growing recognition of polymicrobial disease burdens (Liu et al. 2023; Song et al. 2024; Pujiaty et al. 2024). However, comparable reports in companion animals remain limited. Here, a complex polymicrobial co-infection involving MTBC, Mycobacterium kansasii, and multidrug-resistant opportunistic bacteria is described in a chronically immunosuppressed cat. This case illustrates how conventional diagnostic approaches may fail in such settings and demonstrates the critical role of high-sensitivity molecular tools, including whole genome sequencing, in identifying occult infections (Narimisa et al. 2024; Černá et al. 2020; Lee et al. 2017). These findings underscore the diagnostic and clinical importance of recognizing atypical and polymicrobial mycobacterial infections in immunocompromised companion animals within shared human-animal urban environments. Case presentation On January 28, 2024 (Day 0), an 8-year-old, 4 kg, spayed female American Shorthair cat was referred from a primary clinic for refractory perioral erythema and pruritus. The patient had a history of feline atopy and chronic gingivostomatitis managed for over 2 years with a synergistic immunomodulatory protocol comprising cyclosporine A (CyA; 6.25 mg/kg PO q24h) and intermittent prednisolone (PDS; 1 mg/kg PO q24h, administered as needed [PRN] for acute flare‑ups). At the time of referral, this regimen was maintained to control the underlying immune‑mediated condition. Screening for serum feline immunodeficiency virus (FIV) antibody and feline leukemia virus (FeLV) antigen via rapid ELISA (SNAP Feline Triple Test; IDEXX), and for feline calicivirus (FCV) by real-time PCR (Korea Vet Lab), was negative. Despite continued immunomodulatory therapy with CyA and PDS, clinical signs progressed, with intermittent coughing and increased respiratory effort. By Day 110 (May 17, 2024), following confirmation of feline herpesvirus-1 (FHV-1) recrudescence by PCR, PDS was discontinued and the CyA dose was reduced to 3 mg/kg BID to facilitate viral clearance. This adjustment, however, was followed by rapidly progressive proliferative nodules on the nasal bridge and perioral region (Fig. 1) and severe pododermatitis developing by Day 150. Fig. 1Gross clinical manifestations of multifocal cutaneous lesions (A) Multifocal proliferative nodules on the nasal bridge and perioral region. (B) Focal ulceration with serosanguineous to purulent discharge in perinasal lesions (C) Firm subcutaneous nodules (arrows) around the pinnae Gross clinical manifestations of multifocal cutaneous lesions (A) Multifocal proliferative nodules on the nasal bridge and perioral region. (B) Focal ulceration with serosanguineous to purulent discharge in perinasal lesions (C) Firm subcutaneous nodules (arrows) around the pinnae By Day 240, the patient’s systemic condition deteriorated, manifesting as respiratory distress, progressive weight loss, and marked hyperglycemia (401 mg/dL; RI: 71–148). Given that fructosamine remained within the reference interval (211 µmol/L; RI: 191–349), the hyperglycemia was interpreted cautiously as a possible stress‑induced response. Concurrently, feline serum amyloid A (fSAA) was markedly elevated (180.86 mg/L; RI: 0–10). Physical evaluation revealed bilateral popliteal lymphadenomegaly (Fig. S1), and abdominal ultrasonography identified hypoechoic, irregularly shaped masses near the perirenal and periaortic regions, consistent with visceral lymphadenomegaly. Collectively, these findings suggested a disseminated process, with differential diagnoses including systemic infection, immune-mediated inflammatory disease, or neoplastic processes. Pre‑surgical computed tomography (CT) on Day 262 identified a bilateral nasolabial soft tissue mass extending approximately 2.1 cm from the nostrils to the mid‑level of the hard palate, causing near‑complete nasal obstruction, severe stertor, and dyspnea. No osteolysis was observed in the nasal cavity, hard palate, or mandible. Thoracic imaging showed suspected atelectasis or consolidation in the apical portion of the left cranial lung lobe (Fig. 2). In addition, mild enlargement of the bilateral mandibular (Fig. 2D) and medial retropharyngeal lymph nodes (Fig. 2E) was detected. Fig. 2Computed tomography (CT) analysis of the head and thorax (A) Sagittal view: bilateral nasolabial mass (2.1 cm) extending to the mid-hard palate. (B) Axial view: obstruction of nasal passages (white arrow). (C) Transverse view: preserved nasal turbinates, hard palate, and mandible without osteolysis. (D, E) Mild lymphadenomegaly of the mandibular (D, white arrow) and medial retropharyngeal lymph nodes (E, black arrow). (F) Thoracic section: consolidation in the left cranial lung lobe Computed tomography (CT) analysis of the head and thorax (A) Sagittal view: bilateral nasolabial mass (2.1 cm) extending to the mid-hard palate. (B) Axial view: obstruction of nasal passages (white arrow). (C) Transverse view: preserved nasal turbinates, hard palate, and mandible without osteolysis. (D, E) Mild lymphadenomegaly of the mandibular (D, white arrow) and medial retropharyngeal lymph nodes (E, black arrow). (F) Thoracic section: consolidation in the left cranial lung lobe On Day 263 (October 17, 2024), cytoreductive surgery of the perinasal mass was performed to relieve upper airway obstruction. Diagnostic specimens—including punch biopsies of perioral and periauricular lesions, as well as samples of the perinasal granulomatous lesion and nasal exudates—were collected for multimodal analysis. Preliminary cytology of fine‑needle aspirates (FNA) from the perinasal mass revealed a dense infiltrate of activated macrophages and neutrophils with numerous unstained, rod‑shaped negative images of bacilli (Fig. 3), raising suspicion for Nocardia or Mycobacterium spp. Subsequent histopathological examination of the periauricular punch biopsy revealed a diffuse and dense pyogranulomatous infiltrate involving the dermis and subcutaneous tissue, predominantly composed of large epithelioid macrophages with abundant eosinophilic cytoplasm and oval-to-spindle-shaped nuclei (Fig. 4). Based on clinical severity and cytological findings, empirical therapy was initiated on Day 263 (marbofloxacin 5.65 mg/kg SID, azithromycin 5.65 mg/kg BID, and doxycycline 5.65 mg/kg BID) and continued until Day 270. Fig. 3Cytological analysis of the perinasal mass via fine-needle aspiration (FNA) (A) Mixed inflammatory infiltration predominantly composed of activated macrophages and neutrophils (Diff-Quik stain; bar = 20 μm). (B) High-magnification view showing macrophages containing numerous intracytoplasmic negative images of bacilli (bar = 10 μm) Cytological analysis of the perinasal mass via fine-needle aspiration (FNA) (A) Mixed inflammatory infiltration predominantly composed of activated macrophages and neutrophils (Diff-Quik stain; bar = 20 μm). (B) High-magnification view showing macrophages containing numerous intracytoplasmic negative images of bacilli (bar = 10 μm) Fig. 4Histopathological findings of cutaneous nodular lesions from a periauricular punch biopsy (H&E stain) (A) Low-magnification view: diffuse inflammatory infiltration involving the entire dermis and subcutaneous tissue (bar = 800 μm). (B) High-magnification view: pyogranulomatous infiltrate composed of epithelioid macrophages and interspersed neutrophils (bar = 50 μm) Histopathological findings of cutaneous nodular lesions from a periauricular punch biopsy (H&E stain) (A) Low-magnification view: diffuse inflammatory infiltration involving the entire dermis and subcutaneous tissue (bar = 800 μm). (B) High-magnification view: pyogranulomatous infiltrate composed of epithelioid macrophages and interspersed neutrophils (bar = 50 μm) Despite intensive care, the patient’s condition continued to deteriorate. On Day 270, the cat developed refractory hypotension (systolic blood pressure 45–60 mmHg) and hypothermia (35.3℃) consistent with septic shock, which did not respond to aggressive fluid resuscitation and vasopressor support. Terminal laboratory analysis revealed marked azotemia (blood urea nitrogen 214.7 mg/dL; RI: 17.6–32.8), profound leukocytosis (white blood cells 70.4 K/µL; RI: 5.5–19.5), and severe hypoalbuminemia (albumin 1.5 g/dL; RI: 2.3–3.5), consistent with multi‑organ dysfunction syndrome. Serum amyloid A (SAA) levels exceeded the maximum measurable range, indicating an overwhelming systemic inflammatory response. Concurrently, abdominal ultrasonography identified hypoechoic, irregularly shaped masses near the perirenal and periaortic regions, highly suggestive of visceral lymphadenomegaly. The cat died on Day 270 despite close monitoring and advanced supportive therapy. Because no post-mortem gross examination or systemic microbiology was performed, the terminal event could not be definitively attributed to a single pathogen; however, the clinical, laboratory, and imaging findings collectively supported terminal septic shock associated with a disseminated polymicrobial infectious process. Post‑mortem Ziehl–Neelsen (ZN) staining of periauricular punch biopsy specimens (Fig. 5), originally obtained on Day 263, confirmed a heavy burden of acid‑fast bacilli (AFB) within macrophages and extracellularly, providing definitive histopathologic confirmation of mycobacteriosis. Fig. 5Histopathological identification of mycobacteria in a cutaneous nodule from a periauricular punch biopsy (Ziehl–Neelsen (ZN) stain) Massive burden of bright red, rod-shaped acid-fast bacilli (AFB) within the pyogranulomatous lesion, located both intracytoplasmically and extracellularly (bar = 50 μm) Histopathological identification of mycobacteria in a cutaneous nodule from a periauricular punch biopsy (Ziehl–Neelsen (ZN) stain) Massive burden of bright red, rod-shaped acid-fast bacilli (AFB) within the pyogranulomatous lesion, located both intracytoplasmically and extracellularly (bar = 50 μm) Traditional cultures on 3% Ogawa medium, performed at Masan National Tuberculosis Hospital and incubated at 32 °C and 37 °C according to the laboratory protocol, failed to isolate mycobacteria from nasal granulomatous lesions and inflammatory exudate swabs obtained from the perinasal cavity due to rapid overgrowth of competing flora (Fig. S2, Graph S1, Table S1). To resolve this, post‑mortem whole‑genome sequencing (WGS) using the Illumina MiSeq™ platform was performed on selected tissue and swab specimens. Following quality trimming, clean reads met Illumina MiSeq™ specifications across all samples, with mean quality scores of Q33.5–Q33.8 and 80.9–82.0% of bases ≥ Q30 (Table S2), supporting the reliability of downstream taxonomic classification. Taxonomic classification revealed a dominant bacterial population consistent with K. pneumoniae (79–80% relative abundance; Fig. 6). Simultaneously, targeted high‑sensitivity multiplex real‑time PCR assays—Advansure™ TB/NTM (Invitros, Seoul, Korea) and Gcdia™ MTB/NTM (Genes Lab, Gyeonggi‑do, Korea)—designed to detect both Mycobacterium tuberculosis complex (MTBC) and non‑tuberculous mycobacteria (NTM) were applied to the same composite specimen. MTBC (Ct 32.33–34.44) and NTM (Ct 23.99–29.00) were detected, as detailed in Table 1 (A) (Graph S2). Both commercial kits incorporate an internal control (IC) to monitor amplification efficiency and exclude false-negative results (Table 1A). Although the MTBC Ct values were near the diagnostic threshold, consistent detection across both assays supports the presence of MTBC DNA. Notably, while MTBC was detected by targeted PCR, it was not reliably resolved in the non‑targeted WGS data. Nevertheless, the presence of MTBC DNA was supported by consistent and reproducible amplification across two independent commercial PCR assays. Subsequent sequencing of the NTM-specific internal transcribed spacer (ITS) region identified the NTM component as M. kansasii (Table 1 (B)). Fig. 6Metagenomic profiling of nasal lesions via WGS Sunburst diagrams depicting the microbial community structure across Sample 1, Sample 2, and Sample 3. Taxonomic hierarchy demonstrates an overwhelming dominance of K. pneumoniae, accounting for 79–80% of the total microbial reads. Sample 1, granulomatous tissue including ulcerated and necrotic debris; Sample 2, inflammatory exudate swab for PCR; Sample 3, inflammatory exudate swab for culture Metagenomic profiling of nasal lesions via WGS Sunburst diagrams depicting the microbial community structure across Sample 1, Sample 2, and Sample 3. Taxonomic hierarchy demonstrates an overwhelming dominance of K. pneumoniae, accounting for 79–80% of the total microbial reads. Sample 1, granulomatous tissue including ulcerated and necrotic debris; Sample 2, inflammatory exudate swab for PCR; Sample 3, inflammatory exudate swab for culture Table 1Molecular identification and species-level characterization of mycobacteria (A) Real-time PCR results with Ct values and diagnostic interpretations. (B) Species-level identification of NTM via internal transcribed spacer (ITS) sequencing(A)SamplesPCR kitsAdvansureTM TB/NTM real-time PCR kitGcdiaTM MTB/NTM Real-Time PCR kitTB*NTMICResultTB*NTMICResult1No Ct29.0030.65NTMNo Ct23.9926.02NTM232.3328.8026.80MIX34.4428.6825.98MIX3No Ct27.0427.13NTMNo Ct26.0426.01NTM(B)SamplesTop Identification OrganismTop scoreNumber of HitsConclusion1 Mycobacterium kansasii 12649 Mycobacterium kansasii 2 Mycobacterium kansasii 12449 Mycobacterium kansasii 3 Mycobacterium kansasii 11949 Mycobacterium kansasii †Note: Sample 1–3 represent sub-samples derived from the nasal granulomatous lesion (Sample 3, Supplemental materials 1.2): Sample 1, granulomatous tissue including ulcerated and necrotic debris; Sample 2, inflammatory exudate swab for PCR; Sample 3, inflammatory exudate swab for cultureAbbreviations: MTB, Mycobacterium tuberculosis complex (MTBC); NTM, non-tuberculous mycobacteria; MIX, co-infection of MTBC and NTM; IC, internal contro;l Ct, threshold cycle*TB, detection of MTBC; species‑level identification was not performedPositive result defined as Ct < 35 Table 1Molecular identification and species-level characterization of mycobacteria (A) Real-time PCR results with Ct values and diagnostic interpretations. (B) Species-level identification of NTM via internal transcribed spacer (ITS) sequencing(A)SamplesPCR kitsAdvansureTM TB/NTM real-time PCR kitGcdiaTM MTB/NTM Real-Time PCR kitTB*NTMICResultTB*NTMICResult1No Ct29.0030.65NTMNo Ct23.9926.02NTM232.3328.8026.80MIX34.4428.6825.98MIX3No Ct27.0427.13NTMNo Ct26.0426.01NTM(B)SamplesTop Identification OrganismTop scoreNumber of HitsConclusion1 Mycobacterium kansasii 12649 Mycobacterium kansasii 2 Mycobacterium kansasii 12449 Mycobacterium kansasii 3 Mycobacterium kansasii 11949 Mycobacterium kansasii †Note: Sample 1–3 represent sub-samples derived from the nasal granulomatous lesion (Sample 3, Supplemental materials 1.2): Sample 1, granulomatous tissue including ulcerated and necrotic debris; Sample 2, inflammatory exudate swab for PCR; Sample 3, inflammatory exudate swab for cultureAbbreviations: MTB, Mycobacterium tuberculosis complex (MTBC); NTM, non-tuberculous mycobacteria; MIX, co-infection of MTBC and NTM; IC, internal contro;l Ct, threshold cycle*TB, detection of MTBC; species‑level identification was not performedPositive result defined as Ct < 35 Molecular identification and species-level characterization of mycobacteria (A) Real-time PCR results with Ct values and diagnostic interpretations. (B) Species-level identification of NTM via internal transcribed spacer (ITS) sequencing †Note: Sample 1–3 represent sub-samples derived from the nasal granulomatous lesion (Sample 3, Supplemental materials 1.2): Sample 1, granulomatous tissue including ulcerated and necrotic debris; Sample 2, inflammatory exudate swab for PCR; Sample 3, inflammatory exudate swab for culture Abbreviations: MTB, Mycobacterium tuberculosis complex (MTBC); NTM, non-tuberculous mycobacteria; MIX, co-infection of MTBC and NTM; IC, internal contro;l Ct, threshold cycle *TB, detection of MTBC; species‑level identification was not performed Positive result defined as Ct < 35 Furthermore, antimicrobial susceptibility testing (AST) identified concurrent multidrug-resistant (MDR) Pseudomonas aeruginosa in the nasal inflammatory exudate (Fig. S3). The isolate was confirmed by standard phenotypic methods and disk diffusion AST performed at a commercial veterinary diagnostic laboratory (Korea Vet Lab, Gyeonggi, Korea) according to the Clinical and Laboratory Standards Institute (CLSI) breakpoints, and showed resistance to multiple antibiotic classes, including penicillin, cephalosporin, and tetracycline. Based on these diagnostic findings, the patient was considered to have a fatal quadruple microbial profile comprising MTBC, M. kansasii, K. pneumoniae, and MDR P. aeruginosa. Discussion and conclusions This report represents a rare documented feline case of a fatal co-infection involving Mycobacterium tuberculosis complex (MTBC), Mycobacterium kansasii (M. kansasii, a non‑tuberculous mycobacterial [NTM] species), Klebsiella pneumoniae (K. pneumoniae), and MDR Pseudomonas aeruginosa (P. aeruginosa). The clinical course in this patient was consistent with disseminated mycobacteriosis, characterized by multifocal cutaneous involvement (nasofacial, perioral, periauricular, pedal regions), systemic lymphadenopathy, and secondary pulmonary changes. Multimodal imaging, together with cytological findings from the perinasal mass, suggested a systemic process compatible with potential lymphatic and hematogenous dissemination, as indicated by bilateral popliteal lymphadenomegaly (Fig. S1), enlargement of the mandibular and medial retropharyngeal lymph nodes (Fig. 2D, E), perirenal/periaortic visceral lymphadenomegaly, and pulmonary consolidation. Taken together, these findings support the presence of an advanced disseminated polymicrobial infection that may have reflected the combined burden of the underlying mycobacterial disease and concurrent opportunistic bacterial overgrowth (such as K. pneumoniae and MDR P. aeruginosa), and was temporally associated with terminal septic shock. Previous reports of feline M. kansasii infection from Japan, the UK, and South Korea described cases that responded to prolonged treatment (Černá et al. 2020; Fukano et al. 2021; Lee et al. 2017). In contrast, the fatal trajectory in this patient underscores management challenges associated with profound iatrogenic immunosuppression (ABCD Guidelines 2024; Gunn-Moore 2014; Webster et al. 2022). Chronic cyclosporine A (CyA) exposure may have impaired the T-cell–macrophage axis by suppressing T-cell activation and production of key cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-γ) (Motiee et al. 2022), thereby reducing effective macrophage activation and mycobactericidal function. In this setting, inflammatory cells may still be recruited to the lesion, but their functional sequestration may be impaired, potentially contributing to poor granuloma organization and accelerated clinical progression. Histopathology revealed pyogranulomatous dermatitis in the ear tip nodules lacking well-organized granuloma architecture. While such atypical architecture has also been reported in feline mycobacteriosis regardless of immune status (Mitchell et al. 2022), the additional suppressive effect of corticosteroids may have exacerbated this pattern in the present case. Prednisolone (PDS) concurrently suppresses macrophage-mediated phagocytosis and inflammatory signaling (Webster et al. 2022). Notably, CT revealed no osteolysis despite a substantial nasolabial inflammatory mass (Fig. 2). Bone involvement and osteolysis are reported only in a minority of feline mycobacteriosis cases (approximately 24%) (Bennett et al. 2011; Gunn-Moore 2014), and the complete preservation of osseous structures in this patient therefore remains a noteworthy but not pathognomonic observation. In mycobacterial disease, bone destruction is typically mediated by host-derived cytokines that promote osteoclastogenesis (Gunn-Moore 2014; Mitchell et al. 2022). In the present case, pharmacologic immunosuppression may have contributed to the preserved maxillofacial bone structures, although this possibility remains speculative. Although specialized assays (e.g., therapeutic drug monitoring or dynamic IL-2 studies) were unavailable to objectively quantify the degree of immunosuppression, the absence of bone remodeling remains noteworthy. The relationship between iatrogenic immunosuppression and bone remodeling in feline mycobacteriosis is complex and warrants further investigation; the preserved osseous structures in this case should therefore be interpreted as a descriptive finding rather than evidence of a direct causal effect. Beyond the radiological observations, the localized microbiological profile of the nasal lesion clarified a major diagnostic challenge. The discrepancy between non-targeted WGS and targeted real-time PCR is best explained by a technical limitation of metagenomic sequencing in high-background samples, where the overwhelming abundance of K. pneumoniae likely reduced MTBC read representation below reliable detection levels. In contrast, targeted PCR bypasses this background through sequence‑specific amplification. The consistent dual-platform PCR detection also argues against simple technical cross-reactivity with M. kansasii. A critical feature of this case was the delay between clinical deterioration and etiologic identification. Despite antemortem sampling, definitive AFB confirmation and species-level molecular characterization were obtained only after death. Conventional diagnostics were also unable to provide timely resistance profiling for concurrent pathogens. Within this profoundly immunocompromised context, opportunistic organisms such as K. pneumoniae and MDR P. aeruginosa may have further complicated the disease course, and both were suspected to have contributed to the rapid decline. However, because these bacteria were isolated only from local lesions and no blood cultures were obtained, their exact systemic contribution cannot be determined definitively. From a One Health perspective, the concurrent detection of MTBC and M. kansasii in a domestic cat raises potential zoonotic and reverse-zoonotic considerations (Commandeur et al. 2025; Didkowska et al. 2024; Fukano et al. 2021). While M. kansasii is typically an environmental NTM acquired from water or related reservoirs (Narimisa et al. 2024), the epidemiology of MTBC infection in feline patients is distinct. Domestic cats are generally considered relatively resistant to M. tuberculosis infection, and most feline MTBC cases have historically been attributed to M. bovis or M. microti, often associated with wildlife or environmental reservoirs (ABCD Guidelines 2024; Gunn-Moore et al. 2011; Sykes and Greene 2022). Accordingly, zoonotic transmission associated with companion cats remains rare and has been reported predominantly in relation to M. bovis. In the present case, MTBC detection in a profoundly immunosuppressed household cat should be interpreted cautiously, as altered host immunity may have affected the animal’s susceptibility to infection. Rather than indicating routine cat-to-human transmission, the finding may be viewed as a cautious indicator of possible exposure within the shared household environment (Fig. 7). This distinction is important when considering public-health implications. Reverse-zoonotic investigation and notification protocols are primarily established for dogs, which are recognized as susceptible to M. tuberculosis, whereas feline MTBC infection remains rare and no routine parallel screening protocol is established for cats. In feline cases such as this one, any consideration of household contact investigation should therefore be made cautiously and on a case-by-case basis, particularly when MTBC is detected in an immunosuppressed patient. The diagnostic implications of this case are more directly actionable. Rapid cytology and Ziehl–Neelsen (ZN) staining should be considered in any patient in whom mycobacterial infection is part of the differential diagnosis, regardless of immune status. In immunosuppressed veterinary patients, a tiered strategy may be particularly useful: (1) rapid cytology and ZN staining for immediate AFB detection; (2) early targeted real-time PCR for MTBC/NTM to bypass culture overgrowth and competitive inhibition by opportunistic flora; and (3) confirmatory culture and WGS for species-level characterization and resistance profiling when clinically indicated. Such an approach may improve timely diagnosis and, in selected circumstances, provide information relevant to broader One Health surveillance. This case also has several limitations. It was a single-case study without systemic microbiology, such as blood cultures, to confirm bacteremia as the cause of the terminal event. The source of the MTBC infection could not be established, and successful mycobacterial isolation was not achieved, precluding species-specific susceptibility testing and detailed phenotypic characterization. Specialized assays to quantify the degree of immunosuppression were unavailable. Finally, the relative contribution of MTBC, M. kansasii, K. pneumoniae, and MDR P. aeruginosa to the lesions and overall outcome cannot be determined with certainty. In summary, this case underscores the need for a multifaceted diagnostic strategy in immunosuppressed veterinary patients with suspected mycobacteriosis. Reliance on conventional culture alone may be insufficient when rapid overgrowth of competing flora obscures slow-growing pathogens. Early integration of cytology, acid-fast staining, and targeted molecular testing may shorten the interval from sampling to etiologic suspicion and improve clinical decision-making. When culture is attempted, standardized decontamination procedures may also improve recovery of slow-growing mycobacteria in future diagnostic workflows. Fig. 7Integrative clinical timeline and One Health transmission dynamics of disseminated mycobacteriosis in a chronically immunosuppressed cat The schematic illustrates the 9-month progression of fatal disseminated mycobacteriosis in an 8-year-old immunosuppressed cat. (Top) One Health framework depicting potential bidirectional transmission pathways at the human-cat-environment interface, illustrating the context in which domestic animals may potentially contribute to the detection of circulating mycobacterial strains. (Bottom) Detailed clinical timeline correlating long-term immunosuppressive therapy with emergence of refractory perioral nodules, respiratory distress, stress-induced hyperglycemia, and systemic complications (Days 0–270). Key diagnostic milestones include post-mortem histopathological detection of abundant acid-fast bacilli (AFB) and molecular identification of quadruple co-infection: M. tuberculosis complex (MTBC)/M. kansasii alongside dominant K. pneumoniae and MDR P. aeruginosa Integrative clinical timeline and One Health transmission dynamics of disseminated mycobacteriosis in a chronically immunosuppressed cat The schematic illustrates the 9-month progression of fatal disseminated mycobacteriosis in an 8-year-old immunosuppressed cat. (Top) One Health framework depicting potential bidirectional transmission pathways at the human-cat-environment interface, illustrating the context in which domestic animals may potentially contribute to the detection of circulating mycobacterial strains. (Bottom) Detailed clinical timeline correlating long-term immunosuppressive therapy with emergence of refractory perioral nodules, respiratory distress, stress-induced hyperglycemia, and systemic complications (Days 0–270). Key diagnostic milestones include post-mortem histopathological detection of abundant acid-fast bacilli (AFB) and molecular identification of quadruple co-infection: M. tuberculosis complex (MTBC)/M. kansasii alongside dominant K. pneumoniae and MDR P. aeruginosa Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1